Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 5/20 | 0.55 |
| ▸ | CES2 | O00748 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | DAO | P14920 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21352312 | 0.83 | CES1 (0.44) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL543379 | 0.80 | CES1 (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL27510084 | 0.78 | CES1 (0.50) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL4417015 | 0.78 | CES1 (0.50) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL1608946 | 0.76 | CES1 (0.48) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL28143072 | 0.76 | CES1 (0.48) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL5164356 | 0.76 | CES1 (0.48) | CES1CES2TSHRALDH1A1DAO | |
| Benzophenone SCHEMBL29023256 | 0.75 | ALDH1A1 (0.93) | CES1CES2TSHRALDH1A1DAO | |
| Benzophenone SCHEMBL28761922 | 0.75 | ALDH1A1 (0.93) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL4353525 | 0.74 | CES1 (0.64) | CES1CES2TSHRALDH1A1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10266409-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2019-04-23 | — | — | US | claimed |
| US-8884273-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2014-11-11 | — | — | US | claimed |
| US-7557028-B1 | For example, making indium phosphide (InP)semiconductors starting from tribenzoyl phosphine and tris-cyclopentadienyl indium; use in photovoltaic devices and light emitting diodes | NANOSYS, INC. (US) | 2009-07-07 | — | — | US | claimed |
| US-10266409-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-10029972-B2 | Use of heteroleptic indium hydroxides as precursors for INP nanocrystals | NANOSYS, INC. (US) | 2018-07-24 | — | — | US | disclosed |
| US-9884763-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-9688534-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170137360-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | SHOEI CHEMICAL INC. (JP) | 2017-05-18 | — | — | US | disclosed |
| WO-2017083483-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | NANOSYS, INC. (US) | 2017-05-18 | — | — | WO | disclosed |
| US-9469538-B1 | Process for group III-IV semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2016-10-18 | — | — | US | disclosed |
| US-8884273-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-8062967-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-7557028-B1 | For example, making indium phosphide (InP)semiconductors starting from tribenzoyl phosphine and tris-cyclopentadienyl indium; use in photovoltaic devices and light emitting diodes | NANOSYS, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| EP-0779891-B1 | NOVEL ACYLPHOSPHINE OXIDES | CIBA GEIGY AG (CH) | 1998-12-23 | — | — | EP | disclosed |
| US-5721292-A | PHOTOPOLYMERIZATION INITIATOR | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-02-24 | — | — | US | disclosed |
| EP-0805159-A1 | Phosphorus containing alkyl or arylsulphonyl derivatives and method for preparing same | Cytec Canada Inc. (CA) | 1997-11-05 | — | — | EP | disclosed |
| EP-0779891-A1 | NOVEL ACYLPHOSPHINE OXIDES | Ciba SC Holding AG (CH) | 1997-06-25 | — | — | EP | disclosed |
| WO-1996007662-A1 | NOVEL ACYLPHOSPHINE OXIDES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029972-B2 | Use of heteroleptic indium hydroxides as precursors for INP nanocrystals | INPP5A, INPP5B, INPPL1 | CES1 4699/4885CES2 3332/4885TSHR 4710/4885 |
| US-20170137360-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | INPP5A, INPP5B, INPPL1 | CES1 4699/4885CES2 3332/4885TSHR 4710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.